Remove tag fraud
article thumbnail

Benefits of blockchain in limiting counterfeit drug distribution

European Pharmaceutical Review

Prioritising for a data-driven 2023 An example shared in the paper were paperless mechanisms using blockchain provide an unchangeable and decentralised system for preventing fraud. Blockchain offers the possibility of non-modifiable data uploading with traceability and low-cost data storage.

93
article thumbnail

DOJ Investigates $250 Million in U.S. Sales of Counterfeit Drugs Using Fake DSCSA Pedigrees

Policy Prescription

FDA-OCI’s webpage 3 lists a steady stream of arrests and convictions on various medical frauds, but none relating to the Gilead case.” What goes unstated is how much of the $78 million in drug products were legitimate and safe drugs, tagged as “unapproved” or “misbranded,” versus counterfeit drugs. Emphasis added). .

FDA 40
article thumbnail

Ep. 005 – Dave Chase Podcast Transcript

Pharma Marketing Network

I mean, you know, there has obviously been a lot of breakthrough biologics and different therapeutics like around cancers and things like that, that have high price tags because maybe they don’t have as big a market as you know, something’s wrong, you know blood pressure medication. So yeah, there is plenty to talk about there.